enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
1.640
-0.090 (-5.20%)
May 22, 2026, 4:00 PM EDT - Market closed
enGene Therapeutics Market Cap
enGene Therapeutics has a market cap or net worth of $109.86 million as of May 22, 2026. Its market cap has decreased by -36.43% in one year.
Market Cap
109.86M
Enterprise Value
-132.62M
1-Year Change
-36.43%
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since February 1, 2022, enGene Therapeutics's market cap has decreased from $155.91M to $109.86M, a decrease of -29.54%. That is a compound annual growth rate of -7.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 109.86M | -81.84% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NRx Pharmaceuticals | 116.55M |
| Kalaris Therapeutics | 113.12M |
| Coya Therapeutics | 112.83M |
| Cognition Therapeutics | 112.59M |
| Alps Group | 112.05M |
| Inovio Pharmaceuticals | 110.62M |
| Rani Therapeutics Holdings | 106.80M |
| Cibus | 105.27M |